Your browser doesn't support javascript.
loading
A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.
Drögemöller, Britt I; Wright, Galen E B; Trueman, Jessica; Shaw, Kaitlyn; Staub, Michelle; Chaudhry, Shahnaz; Miao, Fudan; Higginson, Michelle; Groeneweg, Gabriella S S; Brown, James; Magee, Laura A; Whyte, Simon D; West, Nicholas; Brodie, Sonia M; Jong, Geert 't; Israels, Sara; Berger, Howard; Ito, Shinya; Rassekh, Shahrad R; Sanatani, Shubhayan; Ross, Colin J D; Carleton, Bruce C.
Affiliation
  • Drögemöller BI; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Co
  • Wright GEB; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Canada; Department of Pharmacology and Therapeutics, Rad
  • Trueman J; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada.
  • Shaw K; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada.
  • Staub M; Clinical Research Unit, Children's Hospital Research Institute of Manitoba, Canada.
  • Chaudhry S; Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Canada.
  • Miao F; British Columbia Children's Hospital Research Institute, Canada.
  • Higginson M; British Columbia Children's Hospital Research Institute, Canada.
  • Groeneweg GSS; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada.
  • Brown J; British Columbia Women's Hospital and Health Centre, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada.
  • Magee LA; School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College, UK.
  • Whyte SD; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada; Department of Pediatric Anesthesia, British Columbia Children's Hospital, Canada.
  • West N; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada; Department of Pediatric Anesthesia, British Columbia Children's Hospital, Canada.
  • Brodie SM; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada.
  • Jong G'; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Canada; Clinical Research Unit, Children's Hospital Research Institute of Manitoba, Canada; Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences,
  • Israels S; Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada.
  • Berger H; Department of Obstetrics and Gynecology, St. Michael's Hospital, Canada; Epi Methods Consulting, Canada.
  • Ito S; Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Canada.
  • Rassekh SR; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, Children's Heart Centre, BC Children's Hospital, University of British Columbia,
  • Sanatani S; Division of Cardiology, Department of Pediatrics, Children's Heart Centre, BC Children's Hospital, University of British Columbia, Canada.
  • Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada.
  • Carleton BC; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Translational Therapeutics, Department of Pediatrics, University o
Biomed Pharmacother ; 148: 112684, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35149390
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ondansetron / Antiemetics Type of study: Prognostic_studies Limits: Child / Female / Humans / Pregnancy Language: En Journal: Biomed Pharmacother Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ondansetron / Antiemetics Type of study: Prognostic_studies Limits: Child / Female / Humans / Pregnancy Language: En Journal: Biomed Pharmacother Year: 2022 Type: Article